Summary
UnitedHealth Group's first quarter 2014 report shows a 5% increase in total revenues, reaching $31.7 billion, driven by growth in both the UnitedHealthcare and Optum segments. Despite revenue growth, net earnings attributable to common shareholders decreased by 8% to $1.1 billion, or $1.10 per diluted share, down from $1.19 billion ($1.16 per share) in the prior year's quarter. This decline was influenced by increased operating costs, including the new Health Reform Legislation industry tax, and reductions in Medicare Advantage funding. The company saw a 29% revenue jump in its Optum platform, highlighting its strategic importance and growth potential. The balance sheet reflects total assets of $84.6 billion as of March 31, 2014, up from $81.9 billion at year-end 2013. Total liabilities also increased, primarily due to higher medical costs payable and accounts payable. Shareholders' equity saw a modest increase, supported by retained earnings and offset by share repurchases and dividends. Operating cash flow remained strong at $1.4 billion. The company continues to navigate a complex regulatory environment, including the impact of the Affordable Care Act (ACA) fees and Medicare funding adjustments, while also actively returning capital to shareholders through share repurchases and dividends.
Financial Highlights
54 data points| Revenue | $31.71B |
| Cost of Revenue | $892.00M |
| Gross Profit | $30.82B |
| SG&A Expenses | $5.19B |
| Operating Expenses | $29.65B |
| Operating Income | $2.05B |
| Interest Expense | $160.00M |
| Net Income | $1.10B |
| EPS (Basic) | $1.12 |
| EPS (Diluted) | $1.10 |
| Shares Outstanding (Basic) | 983.00M |
| Shares Outstanding (Diluted) | 996.00M |
Key Highlights
- 1Total revenues increased by 5% to $31.7 billion, driven by a 4% rise in UnitedHealthcare and a significant 29% increase in Optum revenues.
- 2Net earnings attributable to common shareholders decreased by 8% to $1.1 billion, resulting in diluted EPS of $1.10, down from $1.16 in Q1 2013.
- 3The introduction of the Health Reform Legislation (ACA) industry tax negatively impacted the effective income tax rate and increased operating costs, contributing to the earnings decline.
- 4Medicare Advantage funding reductions and sequestration led to an estimated negative per share impact of over $0.10.
- 5OptumRx revenue surged by 44% due to insourcing of UnitedHealthcare commercial customers and growth from external clients.
- 6Operating cash flow remained robust at $1.4 billion for the quarter.
- 7The company repurchased $911 million of its common stock and paid $276 million in dividends, demonstrating a commitment to returning capital to shareholders.